BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24895285)

  • 1. Kinetics and utilization of lipid sources during acute exercise and acipimox.
    Nellemann B; Søndergaard E; Jensen J; Pedersen SB; Jessen N; Jørgensen JO; Nielsen S
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E199-208. PubMed ID: 24895285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
    Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of fatty acids at rest and during exercise: regulatory mechanisms.
    Jensen MD
    Acta Physiol Scand; 2003 Aug; 178(4):385-90. PubMed ID: 12864743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten weeks of aerobic training does not result in persistent changes in VLDL triglyceride turnover or oxidation in healthy men.
    Nellemann B; Christensen B; Vissing K; Thams L; Sieljacks P; Larsen MS; Jørgensen JO; Nielsen S
    Eur J Endocrinol; 2014 Nov; 171(5):603-13. PubMed ID: 25117466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state.
    van Loon LJ; Koopman R; Stegen JH; Wagenmakers AJ; Keizer HA; Saris WH
    J Physiol; 2003 Dec; 553(Pt 2):611-25. PubMed ID: 14514877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men.
    Tsekouras YE; Magkos F; Kellas Y; Basioukas KN; Kavouras SA; Sidossis LS
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E851-8. PubMed ID: 18664593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise.
    Zderic TW; Davidson CJ; Schenk S; Byerley LO; Coyle EF
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E217-25. PubMed ID: 14559721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of moderate exercise on VLDL₁ and Intralipid kinetics in overweight/obese middle-aged men.
    Al-Shayji IA; Caslake MJ; Gill JM
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E349-55. PubMed ID: 22094472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men.
    Magkos F; Patterson BW; Mohammed BS; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1568-74. PubMed ID: 17264219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
    Diabetes; 1998 May; 47(5):779-87. PubMed ID: 9588450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single bout of resistance exercise improves postprandial lipid metabolism in overweight/obese men with prediabetes.
    Bittel AJ; Bittel DC; Mittendorfer B; Patterson BW; Okunade AL; Yoshino J; Porter LC; Abumrad NA; Reeds DN; Cade WT
    Diabetologia; 2020 Mar; 63(3):611-623. PubMed ID: 31873788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exercise-induced changes in basal VLDL-triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance than endurance exercise.
    Magkos F; Tsekouras YE; Prentzas KI; Basioukas KN; Matsama SG; Yanni AE; Kavouras SA; Sidossis LS
    J Appl Physiol (1985); 2008 Oct; 105(4):1228-36. PubMed ID: 18669933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced plasma free fatty acid availability during exercise: effect on gene expression.
    Tunstall RJ; McAinch AJ; Hargreaves M; van Loon LJ; Cameron-Smith D
    Eur J Appl Physiol; 2007 Mar; 99(5):485-93. PubMed ID: 17186295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic free fatty acid disposal into very low-density lipoprotein triglycerides.
    Koutsari C; Mundi MS; Ali AH; Patterson BW; Jensen MD
    Diabetes; 2013 Jul; 62(7):2386-95. PubMed ID: 23434937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Acipimox on the metabolism of free fatty acids and very low lipoprotein triglyceride.
    Hannah JS; Bodkin NL; Paidi MS; Anh-Le N; Howard BV; Hansen BC
    Acta Diabetol; 1995 Dec; 32(4):279-83. PubMed ID: 8750769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients.
    Vestergaard ET; Hjelholt AJ; Kuhre RE; Møller N; Larraufie P; Gribble FM; Reimann F; Jessen N; Holst JJ; Jørgensen JOL
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2581-2592. PubMed ID: 30726969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans.
    van Loon LJ; Thomason-Hughes M; Constantin-Teodosiu D; Koopman R; Greenhaff PL; Hardie DG; Keizer HA; Saris WH; Wagenmakers AJ
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E482-93. PubMed ID: 15886227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat oxidation after acipimox-induced reduction in plasma nonesterified fatty acids during exercise at 0 degrees C and 20 degrees C.
    Layden JD; Malkova D; Nimmo MA
    Metabolism; 2004 Sep; 53(9):1131-5. PubMed ID: 15334373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
    Nielsen S; Møller N; Christiansen JS; Jørgensen JO
    Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.